CD8A and tuberculosis: In conclusion, our current study has examined the kinetic expression of classic TRM markers VLA-1 and CD103 and further deciphered the role of VLA-1 integrin, in different phases of CD8 T cell responses following respiratory mucosal vaccination with a replication-defective viral vector TB vaccine.